J. Lamar

发表

Imidazopyridine and Pyrazolopiperidine Derivatives as Novel Inhibitors of Serine Palmitoyl Transferase.

J. Weidner, J. Brozinick, V. Reynolds, 2016, Journal of medicinal chemistry.

P3 cap modified Phe*-Ala series BACE inhibitors.

D. Timm, P. May, Shu-Hui Chen, 2004, Bioorganic & medicinal chemistry letters.

Phe*-Ala-based pentapeptide mimetics are BACE inhibitors: P2 and P3 SAR.

D. Timm, P. May, Shu-Hui Chen, 2004, Bioorganic & medicinal chemistry letters.

P4 and P1' optimization of bicycloproline P2 bearing tetrapeptidyl alpha-ketoamides as HCV protease inhibitors.

J. Glass, Q. Wang, Shu-Hui Chen, 2004, Bioorganic & medicinal chemistry letters.

Discovery of a novel bicycloproline P2 bearing peptidyl alpha-ketoamide LY514962 as HCV protease inhibitor.

J. Glass, B. Heinz, Q. Wang, 2004, Bioorganic & medicinal chemistry letters.

P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl alpha-ketoamide based HCV protease inhibitors.

J. Glass, Q. Wang, Robert B. Johnson, 2004, Bioorganic & medicinal chemistry letters.

Synthesis and evaluation of tripeptidyl α-Ketoamides as human rhinovirus 3C protease inhibitors

Beverly A. Heinz, Shu-Hui Chen, B. Heinz, 2003 .

P4 cap modified tetrapeptidyl alpha-ketoamides as potent HCV NS3 protease inhibitors.

A. Kolykhalov, B. Heinz, Q. Wang, 2004, Bioorganic & Medicinal Chemistry Letters.

Anthranilic amide and imidazobenzothiadiazole compounds disrupt Mycobacterium tuberculosis membrane potential

T. Parish, J. Odingo, Julie V. Early, 2019, MedChemComm.

Anthranilic amide and imidazobenzothiadiazole compounds disruptMycobacterium tuberculosismembrane potential

T. Parish, J. Odingo, Julie V. Early, 2019, MedChemComm.

Design and synthesis of dual peroxisome proliferator-activated receptors gamma and delta agonists as novel euglycemic agents with a reduced weight gain profile.

L. L. Winneroski, G. Etgen, C. Broderick, 2006, Journal of medicinal chemistry.